10 completed, 6 terminated, 4 not yet recruiting, 3 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Jordan Collaborating Cardiology Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan Cardiovascular-renal-metabolic Syndrome | Not yet recruiting | Jordan Collaborating Cardiology Group | 10000 | 2026-07-01 | 2025-12-30 | |
| How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners? Fecal Immunochemical Test (FIT) - Gastrointestinal Bleeding, Antiplatelet Agents | Not yet recruiting | Jordan Collaborating Cardiology Group | 200 | 2026-02-01 | 2026-01-08 | |
| Incidental Findings on Coronary Computed Tomography Angiography CCTA (Review of the scans) - Computed Tomography, Coronary Angiography | Not yet recruiting | Jordan Collaborating Cardiology Group | 2000 | 2026-01-02 | 2025-12-30 | |
| Cardiovascular Risk Factors in Middle Eastern Patients With Stroke Stroke, Low-Density-Lipoprotein-cholesterol Level | Not yet recruiting | Jordan Collaborating Cardiology Group | 2000 | 2025-12-31 | 2025-12-23 | |
| Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents Major Bleeding, Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) | Recruiting | Jordan Collaborating Cardiology Group | 200 | 2025-08-01 | 2025-11-28 | |
| Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms. In-lab polysomnography, Continuous positive airway pressure, Home sleep study device - Obstructive Sleep Apnea, Vasovagal Syncope | Unknown | Jordan Collaborating Cardiology Group | 200 | 2024-03-10 | 2024-09-19 | |
| Cardiovascular Patients With no Standard Modifiable Risk Factors Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients - Cardiovascular Risk Factors | Completed | Jordan Collaborating Cardiology Group | 5540 | 2024-01-22 | 2025-02-25 | |
| Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age Atherosclerotic Cardiovascular Risk, Low-density-lipoprotein (LDL) Cholesterol | Terminated | Jordan Collaborating Cardiology Group | 1000 | 2023-12-11 | 2024-01-31 | |
| Screening for Obstructive Sleep Apnea in Medical Patients Screening for obstructive sleep apnea - Obstructive Sleep Apnea | Withdrawn | Jordan Collaborating Cardiology Group | 2023-10-15 | 2025-02-25 | ||
| Thyroid Profiles in Patients With Acute Illness Performing blood thyroid test (TSH, FT4, FT3) - Thyroid Dysfunction, Acute Illness | Withdrawn | Jordan Collaborating Cardiology Group | 2023-10-15 | 2025-02-25 | ||
| Myocardial Infarction Triggers and Onset in Jordan Study 2 Triggers of Acute Myocardial Infarction, Time of Onset of Acute Myocardial Infarction | Terminated | Jordan Collaborating Cardiology Group | 1000 | 2023-10-01 | 2023-12-29 | |
| Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR ATTR Amyloidosis Wild Type, Severe Aortic Stenosis | Unknown | Jordan Collaborating Cardiology Group | 100 | 2023-10-01 | 2023-08-29 | |
| Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction Iron Deficiency, Heart Failure With Reduced Ejection Fraction | Completed | Jordan Collaborating Cardiology Group | 450 | 2023-09-01 | 2025-02-25 | |
| Tracking of Lipid Lowering Therapy in Jordan Dyslipidemias, Atherosclerotic Cardiovascular Disease | Terminated | Jordan Collaborating Cardiology Group | 1000 | 2022-12-11 | 2024-02-13 | |
| Risk Factors in Young Middle Eastern Women With Cardiovascular Disease Observing cardiovascular risk factors - Cardiovascular Diseases, Risk Factors | Completed | Jordan Collaborating Cardiology Group | 627 | 2021-08-22 | 2024-01-30 | |
| Acute Cardiovascular Events Triggered by COVID-19-Related Stress Acute Myocardial Infarction, Ventricular Tachycardia | Unknown | Jordan Collaborating Cardiology Group | 50 | 2020-05-03 | 2020-05-05 | |
| Statin Eligibility Prior to Myocardial InfarCtion No intervention - Statins, Myocardial Infarction | Terminated | Jordan Collaborating Cardiology Group | 740 | 2019-04-22 | 2019-06-26 | |
| Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population risk factors and revascularization procedures - Risk Factors AND Repeat Revascularization | Completed | Jordan Collaborating Cardiology Group | 1000 | 2018-06-01 | 2023-05-25 | |
| Effect of Low Dose ColchiciNe on the InciDence of POAF Colchicine, Placebo Oral Tablet - Atrial Fibrillation, Cardiac Surgery | Phase 3 | Terminated | Jordan Collaborating Cardiology Group | 254 | 2017-10-02 | 2020-05-01 |
| The Effect of Proton Pump Inhibition on Palpitations Lansoprazole Pill, Placebo - Arrhythmia | Phase 4 | Completed | Jordan Collaborating Cardiology Group | 150 | 2017-05-20 | 2018-08-08 |
Showing 20 of 26. Sign in to see all of them.
Atherosclerosis (3) · Atrial Fibrillation (3) · Arrhythmias, Cardiac (2) · Cardiovascular Diseases (2) · Coronary Artery Disease (2) · Sleep Apnea, Obstructive (2) · Stroke (2) · Syncope, Vasovagal (2) · Acanthosis Nigricans (1) · Acute Coronary Syndrome (1) · Aortic Valve Stenosis (1) · COVID-19 (1) · Death, Sudden, Cardiac (1) · Dyslipidemias (1) · Gastrointestinal Hemorrhage (1)
Colchicine (2) · Continuous Positive Airway Pressure (1) · Dosage Forms (1) · Lansoprazole (1) · Mass Screening (1) · PACEBO protocol (1) · Polysomnography (1) · Rabeprazole (1) · Risk Factors (1) · Thyrotropin (1)
Jordan (23)
Ayman Hammoudeh, MD FACC (2) · Ayman J Hammoudeh, MD, FACC (2) · Ramzi Tabbalat (2) · Ayman Hammoudeh, MD, FACC (1) · Daria Jaara, MD (1) · Imad A Alhaddad, MD, FACC (1) · Imad A. Alhaddad, MD FACC (1) · Laith N Habahbeh, MD (1) · Munir Al Zaqqa, MD (1) · Munir Zaqqa, MD (1) · Munir Zaqqa, MD FACC (1) · Omar Ubaidat, MD (1) · Ramzi A Tabbalat, MD, FACC (1) · Ramzi Tabbalat, MD, FACC (1) · Rand M Zaqqa (1)
PMID 16110718, PMID 24239923, PMID 27502857, PMID 27602082, PMID 30423394, PMID 32720823, PMID 33995586, PMID 39035774, PMID 39931041, PMID 41034877, PMID 41393265, PMID 42572733, PMID 42625571